Updated indications for the recombinant, adjuvanted RSV vaccine

Description

In this Product Explainer Cardiologist Prof Andrew Sindone provides an update on a recombinant, adjuvanted respiratory syncytial virus (RSV) vaccine.

This educational video was developed by Healthed in collaboration with and with funding from GSK.
Views of the speaker are their own and do not necessarily reflect that of GSK. GSK recommends usage in accordance with the Product Information.
PM-AU-RSA-WCNT-250023. Date of approval: May 2025.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Ralph Audehm & Prof Simone Strasser

A/Prof Ralph Audehm & Prof Simone Strasser

Abnormal LFTs – Practical Cases Expert Q&A

Prof Andrew Sindone AM

Prof Andrew Sindone AM

MRAs for Heart Failure Update - New Developments

Prof David Price

Prof David Price

COPD Exacerbation – Inhaled steroids vs Pneumonia Risks – It's Not Black and White

Angela Newbound

Angela Newbound

Practical Strategies to Increase Vaccination Rates This Flu Season

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Andrew Sindone AM

expert

Prof Andrew Sindone AM

Cardiologist; Director of the Heart Failure Unit and Department of Cardiac Rehabilitation, Concord Hospital; Head, Department of Cardiology, Ryde Hospital

Date published: 27 May 2025